CRISPR Therapeutics AG

Common Name
CRISPR Therapeutics
Country
Switzerland
Sector
Healthcare
Industry
Biotechnology
Employees
393
Ticker
CRSP
Exchange
NASDAQ/NMS
Description
Crispr Therapeutics AG is a pioneering biotechnology company specializing in gene editing. Its primary function is to advance the development and application of CRISPR/Cas9 technology, which allows fo...

Disclosures of CRISPR Therapeutics

Explore CRISPR Therapeutics's complete collection of publicly available corporate disclosures, including annual reports, sustainability reports, financial statements, ESG data spreadsheets, and related web publications. Each document is sourced directly from CRISPR Therapeutics's official channels and fully traceable to its official company sources.

The table below lists all of CRISPR Therapeutics's' corporate disclosure by name and reporting period, ensuring full transparency and easy access. Coming soon, Tracenable users will be able to export disclosures as PDFs, view them in Markdown, or open them directly in ChatGPT or Claude for instant analysis and summarization.

NameReporting Period
Annual Report2024
Financial & Extra-Financial Disclosure2024
Financial & Extra-Financial Disclosure2023
Annual Report2023
Annual Report2022
Annual Report2021
Annual Report2020
Annual Report2019
Annual Report2018
Annual Report2017
Annual Report2016
Real-Time Disclosures Datafeed

Get Notified Within Seconds of New Corporate Disclosures

Tracenable is building a high-speed disclosure monitoring system that delivers instant alerts when companies publish new reports or data. Could a real-time datafeed (via SFTP, RSS or API) enhance your investment or analytical workflows?